Caffeic acid induces keratinocyte differentiation by activation of PPAR-α

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 1, 2014, Pages 84-92

  Kim, Bora ^a   Kim, Jin Eun ^a   Kim, Hyun Soo ^b  

^a Enprani Co Ltd   (South Korea)

^b Jungwon University   (South Korea)

Author keywords

caffeic acid; keratinocyte differentiation; peroxisome proliferator activated receptors; structure based pharmacophore screening

Indexed keywords

CAFFEIC ACID; INVOLUCRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR RESPONSIVE ELEMENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REGULATOR PROTEIN; TRANSGLUTAMINASE 1; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; CORNIFIED ENVELOPE; DRUG CYTOTOXICITY; EPIDERMAL PERMEABILITY BARRIER; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PERMEABILITY BARRIER; PROTEIN EXPRESSION;

CAFFEIC ACID; KERATINOCYTE DIFFERENTIATION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; STRUCTURE-BASED PHARMACOPHORE SCREENING;

ANTIOXIDANTS; CAFFEIC ACIDS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; HUMANS; KERATINOCYTES; PERMEABILITY; PPAR GAMMA; TRANSCRIPTIONAL ACTIVATION; TRANSGLUTAMINASES;

EID: 84890994833     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12159     Document Type: Article

References (35)

1. Elias PM,. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005; 125: 183-200.
2. Holleran WM, et al. Permeability barrier requirements regulate epidermal beta-glucocerebrosidase. J Lipid Res 1994; 35: 905-912.
3. Downing DT,. Lipid and protein structures in the permeability barrier of mammalian epidermis. J Lipid Res 1992; 33: 301-313.
4. Lim SW, et al. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-α. J Dermatol 2007; 34: 625-634.
5. Kuenzli S, Saurat JH,. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003; 149: 229-236.
6. Kersten S, et al. Roles of PPARs in health and disease. Nature 2000; 405: 421-424.
7. Schoonjans K, et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 1996; 37: 907-925.
8. Hanley K, et al. Activators of the nuclear hormone receptors PPAR-α and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 1997; 100: 705-712.
9. Rivier M, et al. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998; 111: 1116-1121.
10. Kömüves LG, et al. Stimulation of PPAR-α promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 2000; 115: 353-360.
11. Grunberger D, et al. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988; 44: 230-232.
12. Naczk M, Shahidi F,. Extraction and analysis of phenolics in food. J Chromatogr A 2004; 1054: 95-111.
13. Johnson AA, et al. HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial. Curr Top Med Chem 2004; 4: 1059-1077.
14. Nardini M, et al. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med 1995; 19: 541-552.
15. Okutan H, et al. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 2005; 38: 191-196.
16. Yamada Y, et al. Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice. Photochem Photobiol 2006; 82: 1668-1676.
17. Kim SH, et al. The effects of Musk T on peroxisome proliferator-activated receptor [PPAR]-α activation, epidermal skin homeostasis and dermal hyaluronic acid synthesis. Arch Dermatol Res 2006; 298: 273-282.
18. Hasegawa T, et al. Dietary glucosylceramide enhances cornified envelope formation via transglutaminase expression and involucrin production. Lipids 2011; 46: 529-535.
19. Kim S, et al. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Mol Med 2006; 12: 17-24.
20. Wakita H, Takigawa M,. Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes. J Biol Chem 1999; 274: 37285-37291.
21. Bikle DD, et al. Calcium- and vitamin d-regulated keratinocyte differentiation. Mol Cell Endocrinol 2001; 177: 161-171.
22. Sharma KV, Sisodia R,. Evaluation of the free radical scavenging activity and radioprotective efficacy of Grewia asiatica fruit. J Radiol Prot 2009; 29: 429-443.
23. Sharma OP, Bhat TK,. DPPH antioxidant assay revisited. Food Chem 2009; 113: 1202-1205.
24. Dubrac S, Schmuth M,. PPAR-alpha in cutaneous inflammation. Dermatoendocrinol 2011; 3: 23-26.
25. Lalloyer F, Staels B,. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2010; 30: 894-899.
26. Rosenfield RL, et al. Peroxisome proliferator-activated receptors and skin development. Horm Res Paediatr 2000; 54: 269-274.
27. Balasubramanian S, et al. Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate-dependent differentiation but not apoptosis. Carcinogenesis 2005; 26: 1100-1108.
28. 2+ signaling. J Invest Dermatol 2008; 128: 2166-2178.
29. Kim JH, et al. Enhancement of keratinocyte differentiation by rose absolute oil. Ann Dermatol 2010; 22: 255-261.
30. Hon KL, et al. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D 2013; 13: 37-42.
31. Sarker M, et al. In silico systems biology approaches for the identification of antimicrobial targets. Methods Mol Biol 2013; 993: 13-30.
32. Gülçin I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006; 217: 213-220.
33. Khan AQ, et al. Caffeic acid attenuates 12-O-tetradecanoyl-phorbol-13- acetate (TPA)-induced NF-κB and COX-2 expression in mouse skin: abrogation of oxidative stress, inflammatory responses and proinflammatory cytokine production. Food Chem Toxicol 2012; 50: 175-183.
34. Rajendra Prasad N, et al. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem 2011; 349: 11-19.
35. Song HS, et al. The Effect of caffeic acid on wound healing in skin-incised mice. Korean J Physiol Pharmacol 2008; 12: 343-347.